Customize your JAMA Network experience by selecting one or more topics from the list below.
As 2019 is already an exciting year, I want to say what a privilege it is to edit this journal and to thank all of our readers, authors, peer reviewers,1 and an amazing team of editors and editorial staff that all collaborate to produce JAMA Internal Medicine. We are grateful and energized to have a thoughtful and accomplished group of house staff members and Editorial Fellows and Elective Residents working with us. We have a great team of Teachable Moments Editorial Fellows that are led by Deputy Editor Deborah Grady, MD, University of California–San Francisco. We are accepting applications (as of March 18, 2019, to May 17, 2019, and selection will be announced by June 14, 2019) for the 2019 to 2020 Teachable Moments Editorial Fellow position that is open to internal medicine chief residents across the United States; please find more information and apply at http://ucsfctsi.formstack.com/forms/jama_intmedfellowship2019main.
We also enjoy talking with authors during our monthly author audio interviews. Please subscribe to the JAMA Internal Medicine Author podcast2 and review us on iTunes.
It is a joy to read our authors’ works. We enjoy talking with you at conferences and hearing from you by email or in person. Stories about how publishing in JAMA Internal Medicine boosted your career make our day. We had 2699 submissions of major manuscripts in 2018, with a continued fast turnaround time thanks to the hard work of the editors. The time to an initial decision was a median of 2 days without peer review and 35 days with peer review. The journal had an overall acceptance rate of 12% (6% for research papers). We maintain a high reject without review rate so that authors of manuscripts that we do not publish receive a quick decision, and we only use peer reviewers’ valuable time for manuscripts that we know have a good chance of being published. We were also delighted to receive our highest impact factor ever at 19.99. With submission to JAMA Internal Medicine, authors of articles that are not accepted can now choose referral to another JAMA Network journal, such as JAMA Cardiology or JAMA Oncology, and/or referral to JAMA Network Open.
Our online commenting feature is active and we enjoy hearing from you. We are delighted that more than 142 000 of you follow JAMA Internal Medicine on Twitter and Facebook. Reflecting the broad interest in our content, we were pleased to have 2 articles on the top 100 articles in 2018 according to Altmetric score (a measure of news and social media coverage). You can see the Altmetric score for our top 3 scoring articles (and our leading articles by views/downloads and citations)3-9 (Table) as well as for any article on the journal’s website, and clicking on the link tells you exactly who tweeted, blogged, or covered that article in the media. We also had 27 601 news media impressions and almost 9 million downloads and views of articles in 2018. To keep up with the increasing pace of publishing, we have changed the deadline for submission of Letters to the Editor to 30 days after online first publication so that we can publish Letters in a more timely fashion.
We want to continue publishing your high-quality studies and clinical trials (31 in 2018) as well as Reviews, meta-analyses, Evidence to Practice perspectives, Invited Commentaries, and Teachable Moments from trainees. We strive to publish articles that will help you in your practice of medicine, either teaching something new to improve outcomes or providing information on a practice to avoid for lack of benefits. We will continue to publish articles on the daily challenges in health care and medicine and focus on ways to improve experiences for clinicians and patients as well as approaches to improve health care systems.
The journal could not exist without the generosity of our peer reviewers who give their time and expertise to reviewing papers and offering suggestions for improvements. I thank all of you who are included in the list of peer reviewers.1
Corresponding Author: Rita F. Redberg, MD, MSc, Department of Medicine, University of California–San Francisco, 505 Parnassus, M1180, San Francisco, CA 94143 (firstname.lastname@example.org).
Published Online: March 25, 2019. doi:10.1001/jamainternmed.2019.0508
Conflict of Interest Disclosures: None reported.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Redberg RF. JAMA Internal Medicine—The Year in Review, 2018. JAMA Intern Med. 2019;179(5):612–613. doi:10.1001/jamainternmed.2019.0508
Monkeypox Resource Center